IP Library Granted Patent US 10,849,872
Granted Patent B2
US 10,849,872 · App. 14/790,824 · Granted Dec 1, 2020

Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing the development of diabetes

Inventors: Gabriel Gojon-Zorrilla (San Pedro Garza García, MX); Gabriel Gojon-Romanillos (San Pedro Garza García, MX)
Assignee: NAN Global, LLC
A61K31/277A61K31/205A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,849,872
App. No.
14/790,824
Granted
Dec 1, 2020
Kind
B2
Abstract

The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.

Claims (3)

1. A method for treating obesity without requiring a lifestyle modification or dietary intervention, said method consisting of administering about 20 mg to about 40 mg of tyrphostin 9 or salt thereof and about 2100 mg to about 5600 mg of L-carnitine tartrate within one hour of each other to a human subject in need thereof, wherein said administering is once daily for a duration sufficient for treating obesity.

2. The method of claim 1 , wherein said tyrphostin 9 or salt thereof and said L-carnitine tartrate is administered for at least two weeks.

3. The method of claim 1 , wherein administration of said tyrphostin 9 or salt thereof and said L-carnitine tartrate provides a decrease of plasma glucose or a decrease of plasma triglycerides.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2023
From: MOLECULE X LLC
To: SILTI AG
Reel/Frame 065312/0202 →
CHANGE OF NAME Recorded Oct 23, 2023
From: NAN GLOBAL, LLC
To: MOLECULE X LLC
Reel/Frame 065328/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2016
From: GOJON-ZORRILLA, GABRIEL; GOJON-ROMANILLOS, GABRIEL
To: NAN GLOBAL, LLC
Reel/Frame 039073/0838 →
Continuity (3)
Provisional Application 62127111 · Mar 2, 2015
Provisional Application 62020797 · Jul 3, 2014
Related Publication 20160000745A1 · Jan 7, 2016